South Korea aims 100-day Nipah vaccine plan with AI and mRNA

[Korean News to English Shorts]

The main points are also available on the Journal of Korea YouTube channel.

South Korea aims 100-day Nipah vaccine plan with AI and mRNA

Watch on YouTube: https://www.youtube.com/watch?v=UqXhTfS_Kbo

South Korea is pursuing an ambitious plan to deliver Nipah vaccines within 100 days, leveraging a four-pillar strategy designed to speed up design and production. The approach combines rapid design, robust platforms, and established networks to accelerate development from concept to clinical testing.

A cornerstone of the plan is the use of artificial intelligence to hasten vaccine design, paired with an already ready mRNA platform. Researchers envision two parallel paths: a protein-design route and an mRNA-based shot, both aiming to induce protective immunity against Nipah. Antibody strategies will focus on targeting the virus’s entry proteins to block infection.

Global collaboration is a key element, with aims to connect Phase 1 through Phase 3 trials across international networks. Korea’s policy initiative underscores Nipah as a high-fatality, globally relevant threat, justifying a proactive, cross-border clinical development framework. The effort envisions rapid animal testing today and human trials potentially beginning by 2029.

Domestically, the push supports a biotech sector expansion to reduce dependence on imports for vaccines and related technologies. Officials say the program aligns with broader global health security goals, reinforcing preparedness against emerging pathogens and strengthening supply chains for critical vaccines.

Observers note that if successful, the plan could influence vaccine production and availability beyond Korea, affecting broader regional and even U.S. and global access to Nipah vaccines. The initiative reflects a strategic bet on accelerated science and international cooperation to reshape future pandemic readiness.

Source: https://n.news.naver.com/mnews/article/584/0000036808